Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer ConsortiumPetros Grivas, Shuchi Gulati, Michael A. Thompson et al.|Annals of Oncology|2021Cited by 326
Association of Convalescent Plasma Therapy With Survival in Patients With Hematologic Cancers and COVID-19Michael A. Thompson, KM Steve Lo, Jeffrey P. Henderson et al.|JAMA Oncology|2021Cited by 185
Utilization of COVID-19 Treatments and Clinical Outcomes among Patients with Cancer: A COVID-19 and Cancer Consortium (CCC19) Cohort StudyDonna R. Rivera, Jeremy L. Warner, Solange Peters et al.|Cancer Discovery|2020Cited by 138
The CoVID‐TE risk assessment model for venous thromboembolism in hospitalized patients with cancer and COVID‐19Ang Li, Rachel Rosovsky, Nicole M. Kuderer et al.|Journal of Thrombosis and Haemostasis|2021Cited by 30
Modulation of store-operated Ca2+ entry by cyclic-ADP-riboseMichael A. Thompson, Eduardo N. Chini|Brazilian Journal of Medical and Biological Research|2006Cited by 11